What is Grassi Retina?
Based in Naperville, Illinois, and led by Dr. Michael A. Grassi, Grassi Retina operates as a premier medical practice dedicated to the diagnosis and treatment of complex retinal pathologies. The clinic specializes in addressing critical conditions such as age-related macular degeneration and diabetic retinopathy. By integrating patient-centered care with a commitment to ongoing research and innovative treatment methodologies, the practice has established itself as a vital provider in the regional healthcare landscape. The organization prioritizes a high-touch, informed patient experience, ensuring that clinical excellence is matched by a supportive and professional environment.
How much funding has Grassi Retina raised?
Grassi Retina has raised a total of $70K across 1 funding round:
Debt
$70K
Debt (2021): $70K with participation from PPP
Key Investors in Grassi Retina
PPP
Public-Private Partnership
What's next for Grassi Retina?
With the infusion of this recent capital, Grassi Retina is poised to enter a new phase of operational maturity. The strategic focus will likely shift toward expanding its clinical footprint and integrating cutting-edge diagnostic technologies to improve patient outcomes. As the practice navigates the complexities of the medical retina market, this funding provides the necessary liquidity to support long-term research initiatives and potential facility upgrades. The firm's ability to secure this level of investment highlights its reputation for clinical rigor and its potential for sustained growth in the competitive healthcare services market.
See full Grassi Retina company page
